Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Abingdon, Oxfordshire
SEC filing record 1 source field available
Fiscal year end
31 December
Adaptimmune Therapeutics PLC has filed 808 SEC EDGAR filings since 02 Oct 2014

SEC filing history

Showing 601-625 of 808 matching filings.

Per page
25
Current page
25
4

4

Filing date
03 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
03 Jul 2017
Reporting date
01 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
21 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
06 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
05 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
26 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
25 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
16 May 2017
Reporting date
16 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37368

CT ORDER filing

Filing date
15 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37368

DEF 14A

Filing date
28 Apr 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37368

CT ORDER filing

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37368

PRE 14A

Filing date
12 Apr 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
10 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-37368

10-Q/A

Filing date
06 Apr 2017
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
05 Apr 2017
Reporting date
05 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212713

424B5

Filing date
05 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
30 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .